BBA
YARW

Baker Bros. Advisors’s Yarrow Bioscience YARW Stock Holding History

Baker Bros. Advisors’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,027
Closed -$285K – 98
2025
Q3 		$285K Buy
+17,027
New +$557K ﹤0.01% 87
2020
Q2 		– Sell
-174
Closed -$1.68M – 120
2020
Q1 		$1.68M Sell
174
-20
-10% -$314K 0.01% 94
2019
Q4 		$3.25M Hold
194
– – 0.02% 81
2019
Q3 		$3.14M Hold
194
– – 0.02% 75
2019
Q2 		$4.19M Hold
194
– – 0.03% 66
2019
Q1 		$5.5M Hold
194
– – 0.04% 57
2018
Q4 		$2.88M Hold
194
– – 0.02% 65
2018
Q3 		$6.89M Hold
194
– – 0.05% 62
2018
Q2 		$5.68M Hold
194
– – 0.04% 70
2018
Q1 		$26.3M Buy
+194
New +$23.6M 0.22% 36

Other funds holding YARW

SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
DI
Deeter Investments Austin, Texas $468M AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Baker Bros. Advisors's YARW Position: Q4 2025 in Review

Baker Bros. Advisors sold out of Yarrow Bioscience (YARW) in Q4 2025, closing a stake of 17,027 shares — an estimated $285K sold.

Baker Bros. Advisors first reported a position in YARW in Q1 2018 and held it in 10 quarters. The position peaked at $26.3M in Q1 2018. 42 funds tracked by Wall St. Rank hold YARW as of Q4 2025.

  • Baker Bros. Advisors reported no remaining Yarrow Bioscience position as of Q4 2025 after selling out during the quarter.
  • Baker Bros. Advisors sold 17,027 Yarrow Bioscience shares in Q4 2025, an estimated $285K.
  • Baker Bros. Advisors first reported a position in Yarrow Bioscience in Q1 2018 and held it in 10 quarters.
  • Baker Bros. Advisors's Yarrow Bioscience position peaked at $26.3M in Q1 2018.
  • 42 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q4 2025.

Based on Baker Bros. Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.